RemeGen Co., Ltd. ( REGMF) - Stock Earnings
REGMF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 177.3 million USD | 215.6 million USD |
| 2026Q1 | 47.0 million USD | 94.0 million USD |
| 2026Q2 | 635.4 million USD | 761.8 million USD |
REGMF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -213.5 million USD | 152.0 million USD |
| 2024 | -201.2 million USD | 234.3 million USD |
| 2025 | 98.7 million USD | 452.7 million USD |
| 2026 Est. | — | — |
REGMF
Price: $9.96
52 week price:
Earnings Per Share: 1.55 USD
P/E Ratio: 7.05
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 5.6 billion